{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"ERYTECH Responds to Akkadian\u2019s Disinformation - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rrL2actjqb\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-responds-to-akkadians-disinformation\/\">ERYTECH Responds to Akkadian\u2019s Disinformation<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/erytech-responds-to-akkadians-disinformation\/embed\/#?secret=rrL2actjqb\" width=\"600\" height=\"338\" title=\"&#8220;ERYTECH Responds to Akkadian\u2019s Disinformation&#8221; &#8212; Market Newsdesk\" data-secret=\"rrL2actjqb\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"ERYTECH Responds to Akkadian\u2019s Disinformation \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Akkadian \u2019s challenge of the merger is based on incomplete information and misleading arguments Akkadian has not presented any valuable alternative option Akkadian\u2019s unfounded actions present a risk of destruction of shareholder value and loss of employment at two companies , and the potential loss of a strategically i mportant technology in France In this context, ERYTECH reminds its shareholders of the importance of participating in the Annual General Meeting on June 23 to support the proposed merger with PHERECYDES. Cambridge, MA (U.S.) and Lyon (France) , June 12 , 202 3 , 7:00 am CEST \u2013 ERYTECH Pharma (Nasdaq &amp; Euronext: ERYP), today reacts to a series of disinformation attempts by Akkadian Partners &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNDY1OCM0MDE1NjYzMzAjMjAyMDIzMg=="}